Ironwood Pharmaceuticals
APIs & Drug Manufacturing · Drug Discovery

Ironwood Pharmaceuticals: Risk & public record

Ironwood Pharmaceuticals: 87 research papers in five years.

Data updated Nov 20, 2026 · Back to the company report

What the registers and the postings say about this employer.

Legal entity active
IRONWOOD PHARMACEUTICALS INC
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Public record

Ironwood Pharmaceuticals: 87 research papers in five years.

Research outputpapers its people wrote, per OpenAlex
87papers in five years
8.6kcitations
Gastrointestinal motility and disorders
Medicine
224 papers
Pelvic floor disorders treatments
Medicine
83 papers
Inflammatory Bowel Disease
Medicine
82 papers
Congenital gastrointestinal and neural anomalies
Medicine
34 papers
Health Systems, Economic Evaluations, Quality of Life
Economics, Econometrics and Finance
31 papers

Works most with: AbbVie (United States), Hôpital Beaujon, Universitair Ziekenhuis Leuven, Copenhagen University Hospital, Rigshospitalet, Assistance Publique – Hôpitaux de Paris

Influence
Employees' political contributions, 2026 cycle
20 contributions · their own money, not the company's; names not shown · fec.gov ↗
$1.1k
Patents
Published US applications
20
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.